European Biotech Acquisition Corp. (EBAC)
NASDAQ: EBAC · IEX Real-Time Price · USD
9.78
+0.01 (0.10%)
Jun 24, 2022 4:00 PM EDT - Market closed
0.10%
(1D)
| Market Cap | 160.38M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 2.73M |
| Shares Out | 16.40M |
| EPS (ttm) | 0.14 |
| PE Ratio | 71.39 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 12,693 |
| Open | 9.78 |
| Previous Close | 9.77 |
| Day's Range | 9.78 - 9.78 |
| 52-Week Range | 9.59 - 9.84 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About EBAC
European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands. [Read more...]
Industry
Blank Check / SPAC
IPO Date
Mar 16, 2021
Employees
2
Stock Exchange
NASDAQ
Ticker Symbol
EBAC
News
European Biotech Acquisition Corp. Receives Expected Notification from Nasdaq Related to Delayed Quarterly Report
NEW YORK--(BUSINESS WIRE)--European Biotech Acquisition Corp. receives expected notification from Nasdaq related to delayed quarterly report.